对中国加税包括医药医疗产品吗
版主： Softfist
#8 Re: 对中国加税包括医药医疗产品吗
AI Overview
+9
US-based pharmaceutical companies are increasingly licensing drugs from Chinese firms, with deals rising significantly in recent years, including those for oncology and other therapeutic areas.
Here's a more detailed breakdown:
Rising Trend:
U.S. companies are actively seeking out and licensing drugs developed in China, with the number of deals and the total value of these deals increasing substantially.
Motivations:
Cost-Effectiveness: Chinese biotechs offer a potentially cheaper alternative for acquiring new drug assets.
Innovation: China's biotech sector is rapidly growing, and companies are developing innovative drugs, including those in oncology.
Geopolitical Considerations: Despite some geopolitical tensions, the trend of licensing deals continues.
Examples of Deals:
Merck signed a licensing agreement with Jiangsu Hengrui Pharmaceuticals for a heart disease drug.
Bristol Myers Squibb licensed a HER3/EGFR bispecific antibody-drug conjugate (ADC) product from Biokin Pharma.
AstraZeneca licensed a small molecule GLP-1 receptor agonist from Eccogene.
BioNTech reached a licensing and cooperation agreement with Duality Bio for two ADC pipeline assets.
+9
US-based pharmaceutical companies are increasingly licensing drugs from Chinese firms, with deals rising significantly in recent years, including those for oncology and other therapeutic areas.
Here's a more detailed breakdown:
Rising Trend:
U.S. companies are actively seeking out and licensing drugs developed in China, with the number of deals and the total value of these deals increasing substantially.
Motivations:
Cost-Effectiveness: Chinese biotechs offer a potentially cheaper alternative for acquiring new drug assets.
Innovation: China's biotech sector is rapidly growing, and companies are developing innovative drugs, including those in oncology.
Geopolitical Considerations: Despite some geopolitical tensions, the trend of licensing deals continues.
Examples of Deals:
Merck signed a licensing agreement with Jiangsu Hengrui Pharmaceuticals for a heart disease drug.
Bristol Myers Squibb licensed a HER3/EGFR bispecific antibody-drug conjugate (ADC) product from Biokin Pharma.
AstraZeneca licensed a small molecule GLP-1 receptor agonist from Eccogene.
BioNTech reached a licensing and cooperation agreement with Duality Bio for two ADC pipeline assets.
#10 Re: 对中国加税包括医药医疗产品吗
熟食
中美大船，相向而行，无可奈何花落去。
夫妻梦碎，卖国求辱，同房丫鬟也将就。
沐猴而冠, 傻不厌诈，搬起石头砸自己脚.
三分像人，七分像鬼，英雄做不了奴才也难当
#11 Re: 对中国加税包括医药医疗产品吗
Acetaminophen；Ibuprofen；这类的，虽然品牌或商品名不同，基本都是中国提供的，
还有男人女人的最爱 vigra cialis都是made in China了
还有男人女人的最爱 vigra cialis都是made in China了
